Deoxynojirimycin inhibits mammalian glucosidase 1. As well, it inhibits intestinal and lysosmal alpha-glucosidases, beta-glucosidase from sweet almonds, pancreatic alpha-amylase and amyloglucosidase. Deoxynojirimycin is a potent iminosugar that functions as a glycosidase inhibitor, widely recognized for its impact on carbohydrate metabolism studies. As a crystalline solid, it mimics the structure of glucose, enabling it to competitively bind to glycosidase enzymes and modulate oligosaccharide processing. Its high aqueous solubility and stability make it ideal for in vitro enzymatic assays and mechanistic research. Frequently utilized in glycobiology, Deoxynojirimycin supports investigations into enzyme inhibition, glycoprotein biosynthesis, and carbohydrate-related metabolic pathways.
Products > Life Science > Carbohydrates, Nucleosides & Nucleotides > Carbohydrates | Products > Drug Discovery > Inhibitor | Monosaccharides
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye